Attenuation of experimental TPA-induced dermatitis by acetylenic acetogenins is associated with inhibition of PLA₂ activity

Eur J Pharmacol. 2011 Dec 15;672(1-3):175-9. doi: 10.1016/j.ejphar.2011.09.184. Epub 2011 Oct 2.

Abstract

Topical application of acetylenic acetogenins (AAG) from avocado (0.01-1.0mg/ear), was effective in inhibiting both 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema, and in decreasing tissue myeloperoxidase activity (indicative of polymorphonuclear leukocyte influx). Maximum edema inhibition of 72% was achieved by AAG at lower concentration (0.6 mg/ear) than that of the anti-inflammatory drug indomethacin (2mg/ear). The maximum myeloperoxidase inhibition of 60% was obtained at AAG concentration 0.1mg/ear. Chemical reduction of unsaturated bonds in aliphatic chain of AAG molecules almost abrogated inhibition effect of AAG at high concentration. In vitro AAG administration reduced secretion of PGE(2) in TPA-induced keratinocytes, and inhibited total PLA(2) and sPLA(2) activities in HaCaT cells. The results indicate a topical anti-inflammatory effect of acetylenic acetogenins which is associated with inhibition of PLA(2) activity in skin.

MeSH terms

  • Acetogenins / chemistry*
  • Acetogenins / pharmacology*
  • Acetogenins / therapeutic use
  • Acetylene / chemistry*
  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Cell Line
  • Dermatitis, Contact / drug therapy*
  • Dermatitis, Contact / enzymology*
  • Dermatitis, Contact / etiology
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Enzyme Inhibitors / therapeutic use
  • Humans
  • Male
  • Mice
  • Phospholipase A2 Inhibitors*
  • Phospholipases A2 / metabolism
  • Tetradecanoylphorbol Acetate / adverse effects*

Substances

  • Acetogenins
  • Anti-Inflammatory Agents
  • Enzyme Inhibitors
  • Phospholipase A2 Inhibitors
  • Phospholipases A2
  • Tetradecanoylphorbol Acetate
  • Acetylene